Tumor evolution and chemoresistance in ovarian cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Computer Science Applications,History,Education
Link
http://www.nature.com/articles/s41698-018-0063-0.pdf
Reference116 articles.
1. Meinhold-Heerlein, I. & Hauptmann, S. The heterogeneity of ovarian cancer. Arch. Gynecol. Obstet. 289, 237–239 (2014).
2. Gilks, C. B. et al. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma. Hum. Pathol. 39, 1239–1251 (2008).
3. Meinhold-Heerlein, I. et al. The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications. Arch. Gynecol. Obstet. 293, 695–700 (2016).
4. Koshiyama, M., Matsumura, N. & Konishi, I. Clinical efficacy of ovarian cancer screening. J. Cancer 7, 1311–1316 (2016).
5. Heintz, A. P. et al. Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J. Gynaecol. Obstet. 95(Suppl. 1), S161–S192 (2006).
Cited by 133 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. NIR-triggered NO production combined with photodynamic therapy for tumor treatment;Photodiagnosis and Photodynamic Therapy;2024-10
2. A Clinician's perspective on the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer management;Surgical Oncology;2024-10
3. Multicompartmentalized Microvascularized Tumor-on-a-Chip to Study Tumor-Stroma Interactions and Drug Resistance in Ovarian Cancer;Cellular and Molecular Bioengineering;2024-09-14
4. CRLF1 bridges AKT and mTORC2 through SIN1 to inhibit pyroptosis and enhance chemo-resistance in ovarian cancer;Cell Death & Disease;2024-09-10
5. Development and Validation of a Predictive Model for Resistance to Platinum-Based Chemotherapy in Patients with Ovarian Cancer through Proteomic Analysis;Journal of Proteome Research;2024-09-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3